Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting

Blood

Volumn 113, Issue 21, 2009, Pages 5167-5175

  Keller, Anna M ^a   Xiao, Yanling ^a   Peperzak, Victor ^a   Naik, Shalin H ^a   Borst, Jannie ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; CANCER VACCINE; HLA ANTIGEN CLASS 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; EFFECTOR CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENICS; VACCINATION; ANIMAL; ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD27; ANTIGENS, CD70; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67149117121     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-148007     Document Type: Article

References (50)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426.
2. Acuto O, Michel F. CD28 co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol. 2003;3:939-951. (Pubitemid 37521536)
3. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23-68. (Pubitemid 40563164)
4. Weinberg AD, Rivera MM, Prell R, et al. Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol. 2000;164:2160-2169. (Pubitemid 30108775)
5. Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med. 1997;3:682-685. (Pubitemid 27264981)
6. De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewsky C. OX40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol. 2002;168:661-670. (Pubitemid 34049566)
7. Kjaergaard J, Wang LX, Kuriyama H, Shu S, Plautz GE. Active immunotherapy for advanced intracranial murine tumors by using dendritic cell fusion vaccines. J Neurosurg. 2005;103:156-164. (Pubitemid 43193947)
8. Tirapu I, Arina A, Mazzolini G, et al. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti- CD137 monoclonal antibodies and alloantigens. Int J Cancer. 2004;110:51-60. (Pubitemid 38507203)
9. Ito F, Li Q, Shreiner AB, et al. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res. 2004;64:8411-8419. (Pubitemid 39491781)
10. Yanagita S, Hori T, Matsubara Y, Ishikawa T, Uchiyama T. Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity. Br J Haematol. 2004;124:454-462. (Pubitemid 38230589)
11. Dannull J, Nair S, Su Z, et al. Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. Blood. 2005;105:3206-3213. (Pubitemid 40504341)
12. Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor antigen. J Immunol. 2003;170:2912-2922. (Pubitemid 36302162)
13. Grünebach F, Kayser K, Weck MM, Müller MR, Appel S, Brossart P. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes. Cancer Gene Ther. 2005;12:749-756. (Pubitemid 41208614)
14. Yurkovetsky ZR, Shurin GV, Barry DA, Schuh AC, Shurin MR, Robbins PD. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells. J Gene Med. 2006;8:129-137.
15. Bonehill A, Tuyaerts S, Van Nuffel AM, et al. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. Mol Ther. 2008;16:1170-1180.
16. Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275-281.
17. Sanchez PJ, McWilliams JA, Haluszczak C, Yagita H, Kedl RM. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol. 2007;178:1564-1572. (Pubitemid 46154627)
18. + dendritic cells evoking Th1 and Th17 responses. J Immunol. 2007;179:1449-1457.
19. 2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood. 2009;113:2451-2460.
20. + T cells. J Immunol. 2005;174:710-717.
21. Taraban VY, Rowley TF, Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J Immunol. 2004;173:6542-6546. (Pubitemid 39541037)
22. + T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur J Immunol. 2007;37:716-728.
23. Keller AM, Groothuis TA, Veraar EA, et al. Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules. Proc Natl Acad Sci U S A. 2007;104:5989-5994.
24. Hendriks J, Xiao Y, Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med. 2003;198:1369-1380. (Pubitemid 37392482)
25. + cytotoxic T cell responses in vivo. J Immunol. 2004;172:6039-6046.
26. van Oosterwijk MF, Juwana H, Arens R, et al. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int Immunol. 2007;19:713-718. (Pubitemid 47078715)
27. + T cell-mediated alloimmune responses in vivo. J Immunol. 2005;174:1357-1364.
28. + memory T cells and their capacity for secondary expansion. J Immunol. 2005;175:1665-1676.
29. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1:433-440.
30. Arens R, Tesselaar K, Baars PA, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001;15:801-812. (Pubitemid 34008507)
31. + T cell response after protein immunization. J Immunol. 2008;181:1071-1082.
32. + T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med. 2007;204:1095-1106.
33. Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity. 2008;29:934-946.
34. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001;193:233-238. (Pubitemid 32524454)
35. Banerjee DK, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar KM. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood. 2006;108:2655-2661. (Pubitemid 44777001)
36. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17-27. (Pubitemid 24035278)
37. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184:1953-1962. (Pubitemid 26404485)
38. de Witte MA, Coccoris M, Wolkers MC, et al. Targeting self-antigens through allogeneic TCR gene transfer. Blood. 2006;108:870-877. (Pubitemid 44154619)
39. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005;174:6592-6597.
40. + T cells by exogenous cell-associated antigens. Immunity. 2002;17:211-220.
41. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol. 2006;7:1092-1100. (Pubitemid 44420654)
42. Arens R, Schepers K, Nolte M, van Oosterwijk MF, van Lier RAW. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med. 2004;199:1595-1605. (Pubitemid 38780414)
43. Redmond WL, Sherman LA. Peripheral tolerance of CD8 T lymphocytes. Immunity. 2005;22:275-284.
44. Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol. 2004;4:595-602.
45. + cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol. 2008;180:4615-4620.
46. + T cell tolerance through PD-1 and CTLA-4. Nat Immunol. 2005;6:280-286.
47. Keir ME, Liang SC, Guleria I, et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med. 2006;203:883-895.
48. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 2007;7:543-555. (Pubitemid 46987783)
49. French RR, Taraban VY, Crowther GR, et al. Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation. Blood. 2007;109:4810-4815.
50. +CD25 T cells. Blood. 2007;110:2537-2544.